Skip to main content
Premium Trial:

Request an Annual Quote

Cambridge Sequencing Hub Using Life Tech Instruments

NEW YORK (GenomeWeb News) – Life Technologies said today that it has formed a translational research collaboration with the University of Cambridge that will enable researchers to use the firm’s sequencing technologies through the Eastern Sequence and Informatics Hub at Addenbrooke’s Hospital in Cambridge.

Under the collaboration, European researchers studying cancer, diabetes, and other disorders will be able to use three SOLiD 3 Plus Systems for next generation targeted resequencing and whole transcriptome analysis studies.

The sequencing hub at Cambridge was funded by the UK’s Medical Research Council, the National Institute for Health Research, and the University’s Clinical School. Its mission is to help scientists use genetic information to develop new treatments, diagnostics, and prevention strategies for major diseases.

Cambridge Professor John Todd said in a statement that the sequencing tools will provide researchers with “the throughput and accuracy required for comprehensive characterization of disease programs.

“The translation of this information into clinically relevant knowledge will have a direct impact on the treatment of human disease through the development of better diagnostic, prognostic, and therapeutic agents," Todd added.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.